Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months.

scientific article published on 18 April 2016

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JTHO.2016.03.021
P698PubMed publication ID27103512

P2093author name stringJon Cacicedo
Arturo Navarro-Martin
Ferran Guedea
Valentin Navarro
Ricard Ramos
Maria Arnaiz
Samantha Aso
Rodolfo de Blas
Samuel Rosales
P433issue7
P921main subjectphase II clinical trialQ42824440
P304page(s)1101-1111
P577publication date2016-04-18
P1433published inJournal of Thoracic OncologyQ2448056
P1476titlePhase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months.
P478volume11

Reverse relations

cites work (P2860)
Q38790915A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer
Q36382039Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
Q90095163Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer
Q64969902Early stage lung cancer survival after wedge resection and stereotactic body radiation.
Q89572724Feasibility of stereotactic radiotherapy for lung lesions and conventional radiotherapy for nodal areas in primary lung malignancies
Q49244538Helical Therapy is Safe for Lung Stereotactic Body Radiation Therapy Despite Limitations in Achieving Sharp Dose Gradients
Q42154657Parenchymal and Functional Lung Changes after Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer-Experiences from a Single Institution
Q58801338Real-world treatment patterns for patients 80 years and older with early lung cancer: a nationwide claims study
Q89932945Single-lung stereotactic body radiotherapy: A case report and discussion of therapeutic challenges
Q60912983Stereotactic body radiation therapy for non-small cell lung cancer: A review
Q47108053Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience
Q48238743The TNM 8 M1b and M1c classification for non-small cell lung cancer in a cohort of patients with brain metastases

Search more.